Updated: ImprimisRx's Approval And Superiority Claims For Compounded Drug Draw FDA Warning

 
• By Brenda Sandburg
  
Eye drop compounding
The US FDA objects to promotions for a compounded eye drop product. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Compliance

More from Pink Sheet